Antitumor activity of a new amino acid derivative, N6,N9-bis- (butyloxycarbonylaminomethyl) -L-citrulline
Fujita, H.; Seto, Y.; Sakurai, T.; Ichimura, H.; Satoh, H.; Toyoshima, S.
Gan 69(1): 99-101
1978
ISSN/ISBN: 0016-450X PMID: 205478 Document Number: 131495
Approximately 800 amino acid derivatives were synthesized and screened to evaluate their antitumor activity against various transplantable rat ascites hepatomas. Among them, N8,N9-bis(butyloxycarbonylaminomethyl)-L-citrulline (A-924) was highly effective against various rat ascites hepatomas. A-924, when given orally, exhibited prolongation of survival of rats implanted i.v. with ascites hepatoma cells such as AH-44, AH-66, AH-130, AH-66F or AH-41C.